SE9302005D0 - NEW ACTIVE COMPOUNDS - Google Patents

NEW ACTIVE COMPOUNDS

Info

Publication number
SE9302005D0
SE9302005D0 SE9302005A SE9302005A SE9302005D0 SE 9302005 D0 SE9302005 D0 SE 9302005D0 SE 9302005 A SE9302005 A SE 9302005A SE 9302005 A SE9302005 A SE 9302005A SE 9302005 D0 SE9302005 D0 SE 9302005D0
Authority
SE
Sweden
Prior art keywords
active compounds
new active
compounds
gastric
prevention
Prior art date
Application number
SE9302005A
Other languages
Swedish (sv)
Inventor
Ingemar *Starke Carl
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Priority to SE9302005A priority Critical patent/SE9302005D0/en
Publication of SE9302005D0 publication Critical patent/SE9302005D0/en
Priority to IS4164A priority patent/IS4164A/en
Priority to TW083104301A priority patent/TW261613B/zh
Priority to LTIP1942A priority patent/LT3537B/en
Priority to IL10968594A priority patent/IL109685A/en
Priority to EG33594A priority patent/EG20435A/en
Priority to CN94192410A priority patent/CN1045955C/en
Priority to US08/270,167 priority patent/US5889021A/en
Priority to NZ267740A priority patent/NZ267740A/en
Priority to CA002164875A priority patent/CA2164875A1/en
Priority to CZ953260A priority patent/CZ326095A3/en
Priority to SK1549-95A priority patent/SK154995A3/en
Priority to DE69425823T priority patent/DE69425823T2/en
Priority to BR9406772A priority patent/BR9406772A/en
Priority to JP50167595A priority patent/JP3623794B2/en
Priority to PCT/SE1994/000552 priority patent/WO1994029274A1/en
Priority to HU9503529A priority patent/HUT75122A/en
Priority to PL94311957A priority patent/PL177766B1/en
Priority to RU96100758A priority patent/RU2142454C1/en
Priority to AU70121/94A priority patent/AU680516B2/en
Priority to EP94919046A priority patent/EP0702672B1/en
Priority to ES94919046T priority patent/ES2150494T3/en
Priority to SG1996004567A priority patent/SG47820A1/en
Priority to AT94919046T priority patent/ATE196134T1/en
Priority to EE9400424A priority patent/EE03123B1/en
Priority to US08/351,852 priority patent/US5556863A/en
Priority to NO954928A priority patent/NO305799B1/en
Priority to FI955896A priority patent/FI955896A0/en

Links

Abstract

The present invention is related to new quinoline compounds that can be expressed in formula I:<IMAGE>The compounds suppress gastric acid secretion stimulated from outside and inside, and can therefore be used for prevention and treatment of gastric and intestine inflammatory diseases.
SE9302005A 1993-06-11 1993-06-11 NEW ACTIVE COMPOUNDS SE9302005D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
SE9302005A SE9302005D0 (en) 1993-06-11 1993-06-11 NEW ACTIVE COMPOUNDS
IS4164A IS4164A (en) 1993-06-11 1994-05-11 Compounds that inhibit gastric acid flow
TW083104301A TW261613B (en) 1993-06-11 1994-05-12
LTIP1942A LT3537B (en) 1993-06-11 1994-05-18 Quinoline derivatives
IL10968594A IL109685A (en) 1993-06-11 1994-05-19 Quinoline derivatives process for their preparation and pharmaceutical compositions for inhibition of gastric acid secretion comprising them
EG33594A EG20435A (en) 1993-06-11 1994-06-07 Process for preparing of new active compounds of quinoline derivatives
AT94919046T ATE196134T1 (en) 1993-06-11 1994-06-08 SUBSTITUTED QUINOLINE DERIVATIVES AND THEIR USE AS GASTRIC SECRETION INHIBITORS
DE69425823T DE69425823T2 (en) 1993-06-11 1994-06-08 SUBSTITUTED CHINOLINE DERIVATIVES, AND THEIR USE AS INHIBITORS OF THE GAS secretion
PL94311957A PL177766B1 (en) 1993-06-11 1994-06-08 Novel active compounds
NZ267740A NZ267740A (en) 1993-06-11 1994-06-08 4-n-,3-acyl-,8-o-substituted quinoline derivatives, pharmaceutical compositions and 3-acyl-,8-o-substituted quinoline intermediate
CA002164875A CA2164875A1 (en) 1993-06-11 1994-06-08 New active compounds
CZ953260A CZ326095A3 (en) 1993-06-11 1994-06-08 Novel effective compounds
SK1549-95A SK154995A3 (en) 1993-06-11 1994-06-08 Novel efective compositions
CN94192410A CN1045955C (en) 1993-06-11 1994-06-08 New active compounds
BR9406772A BR9406772A (en) 1993-06-11 1994-06-08 Compound pharmaceutical composition use of the compound processes for preparing the compound for inhibiting gastric acid secretion for the treatment of inflammatory gastrointestinal diseases for the treatment or prophylaxis of conditions Helicobacter pylori infection of human gastric mucosa and pharmaceutical formulation
JP50167595A JP3623794B2 (en) 1993-06-11 1994-06-08 New active compounds
PCT/SE1994/000552 WO1994029274A1 (en) 1993-06-11 1994-06-08 New active compounds
HU9503529A HUT75122A (en) 1993-06-11 1994-06-08 Quinoline derivatives
US08/270,167 US5889021A (en) 1993-06-11 1994-06-08 Active Compounds
RU96100758A RU2142454C1 (en) 1993-06-11 1994-06-08 4-amino-3-acylquinoline derivatives, method of preparation thereof, pharmaceutical agent based thereof, method of preparation of pharmaceutical agent, and intermediate compound
AU70121/94A AU680516B2 (en) 1993-06-11 1994-06-08 New active compounds
EP94919046A EP0702672B1 (en) 1993-06-11 1994-06-08 Substituted quinoline derivatives and their use as inhibitors of gastric acid secretion
ES94919046T ES2150494T3 (en) 1993-06-11 1994-06-08 SUBSTITUTED DERIVATIVES OF QUINOLINE AND ITS USE AS INHIBITORS OF THE GASTRIC ACID SECRETION.
SG1996004567A SG47820A1 (en) 1993-06-11 1994-06-08 New active compounds
EE9400424A EE03123B1 (en) 1993-06-11 1994-11-23 Quinoline derivatives, their manufacturing process, pharmaceutical preparations containing them and their use
US08/351,852 US5556863A (en) 1993-06-11 1994-12-08 Compound for gastric acid secretion inhibition
NO954928A NO305799B1 (en) 1993-06-11 1995-12-05 New quinoline derivatives, pharmaceutical preparations containing such derivatives, their use and intermediates
FI955896A FI955896A0 (en) 1993-06-11 1995-12-08 New active compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302005A SE9302005D0 (en) 1993-06-11 1993-06-11 NEW ACTIVE COMPOUNDS

Publications (1)

Publication Number Publication Date
SE9302005D0 true SE9302005D0 (en) 1993-06-11

Family

ID=20390240

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9302005A SE9302005D0 (en) 1993-06-11 1993-06-11 NEW ACTIVE COMPOUNDS

Country Status (2)

Country Link
LT (1) LT3537B (en)
SE (1) SE9302005D0 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8621425D0 (en) 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804444D0 (en) 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds

Also Published As

Publication number Publication date
LT3537B (en) 1995-11-27
LTIP1942A (en) 1994-12-27

Similar Documents

Publication Publication Date Title
GB2037745B (en) Diphenylbutyl - piperazinecarboxamides
EA200100772A1 (en) BENZOHETEROCYCLES AND THEIR APPLICATION AS MEK INHIBITORS
TW515798B (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
EA200200097A1 (en) IMIDAZOMIDASOLES AND TRIAZOLES AS ANTI-INFLAMMATORY AGENTS
SE9802794D0 (en) New compounds
FI961564A (en) Alkoxyalkylcarbamates of imidazo (1,2-a) pyridines
SE9602286D0 (en) New compounds
EA200200875A1 (en) PROCARE PRODUCTS IMIDAZOPIRIDINE
FI854926A (en) FREEZING FOR PHARMACOLOGICAL ACTIVE PYRROLOBENSIMIDAZOLER.
SE0102808D0 (en) New compounds
WO2000010999A3 (en) New compounds
ES8605507A1 (en) 3-Indolecarboxamide compounds.
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
NO161492C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-CYCLOPROPYL-6-FLUOR-1,4-DIHYDRO-4-OKSO-7- (4- (OCSOALKYL) -1-PIPERAZINYL) -3-CHINOLINE CARBOXYLIC ACID.
SE9302005D0 (en) NEW ACTIVE COMPOUNDS
GR76280B (en)
FI955896A (en) New active compounds
NZ329716A (en) Sulfonamide substituted derivatives and medicaments thereof
NO821083L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE MORPHANTRIDIN DERIVATIVES
MX9704136A (en) Compounds for inhibition of gastric acid secretion.
TH23410B (en) Compounds for inhibiting gastric acid secretion
JPS56122358A (en) Imidazole compound* its manufacture and medicinal composition
KR970702034A (en) Low Dosage Ranitidine Compositions for the Treatment of Minor Gastrointestinal Disorders Associated with Excess Acid Secretion